期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

妥泰的药物相互作用研究进展 被引量：7

暂未订购
导出
摘要 妥泰(TPM)是一种新型的抗癫痫药物,其作用机制复杂。临床上除以单药或与其他药物联合治疗癫痫外,在双相情感障碍、偏头痛等多种疾病治疗也中得到广泛应用。本文就TPM与其它药物之间的相互作用进行综述,为临床合理用药提供参考。
作者 何继红 孙红斌
机构地区 浙江省绍兴市人民医院神经内科 四川省医学科学院.四川省人民医院神经内科
出处 《国际神经病学神经外科学杂志》 2008年第5期445-448,共4页 Journal of International Neurology and Neurosurgery
关键词 妥泰 药物相互作用 临床研究 治疗方法
分类号 R96 [医药卫生—药理学]
  • 相关文献

参考文献21

  • 1何继红,孙红斌.妥泰的临床应用研究进展[J].国际神经病学神经外科学杂志,2006,33(2):153-156. 被引量：3
  • 2Rosenfeld WE, Liao S, Kramer LD, et al. Comparison of the steady-state pharmacokinetics of topiramate and valproate in patients with epilepsy during monntherapy and concomitant therapy. Epilepsia, 1997, 38(3) : 324 -333.
  • 3黄静,任榕娜,陈新民,叶礼燕.抗癫癎药妥泰对幼鼠肝毒性的实验研究[J].中国当代儿科杂志,2007,9(1):54-58. 被引量：3
  • 4Latour P, Biraber A, Polard E, et al. Drug induced enceph- alopathy in six epileptic patients: topiramate? vatproate? or both? Hum Psychopharmacol, 2004, 19(3) : 193-203.
  • 5Mimrod D, Specchio LM, Britzi M, et al. A comparative study of the effect of carbamazepine and valproiee acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy. Epilepsia, 2005 , 46 ( 7 ) : 1046-1054.
  • 6Steinborn B. Pharmaeokinetic interactions of carbamazepine with some antiepileptic drugs during epilepsy treatment in chldren and adolescents. Rocz Akad Med Bialvmst, 2005, (suppl 1):9-15.
  • 7Gisclon LG, Curtin CR, Kramer LD. The steady-state (ss) pharmacokinetics ( PK ) of phenytoin ( Dilantin ) and topiramate in epileptic patients on monotherapy, and during combination therapy. Epilepsia, 1994, 35 ( Suppl 8 ) : 54-55.
  • 8Luszczki JJ, Czuczwar SJ. Gapaentin syrergistically interacts with topiramate in the mouse maximal electroshock seizure model: an isobolographic analysis. Pharmacological Rep, 2006, 58(16) : 944-954.
  • 9Luszczki JJ. lsobolographic analysis of interaction between drugs with nonparallel does-respose relationship curves: a practical application. Naunyn Schmiedebergs Arch Pbarmacol, 2007, 375(2) : 105-114.
  • 10Doose DR, Brodie MJ, Wilson EA, et al. Topiramate and lamotrigine pharmaeokinetics during repetitive monotherapy and combination in epilepsy patients. Epilepsia, 2003 , 44 ( 7 ) : 917-922.

二级参考文献33

  • 1王欣,胡孟英,洪翠翠,刘春华.托吡酯对0～8岁癫痫病儿血清瘦素水平及体重指数的影响[J].中国新药与临床杂志,2005,24(6):457-459. 被引量：2
  • 2Chriatensen J, Andreasen F, Poulsen JH, et al, Randomized,concentration-controlled trial of topiramate in refractory focal epilepsy. Neurology, 2003, 61 (9) : 1210-1218.
  • 3Aykutlu E, Baykan B, Gurses C, et al. Add-on therapy with topiramate in progressive myoelonie epilepsy. Epilepsy Behav,2005, 6(2) : 260-263.
  • 4Arroyo S, Dodson WE, Privitera MD, et al. Randomized dosecontrolled study of topiramate as first-line therapy in epilepsy.Aeta Neural Scand, 2005, 112(4) : 214-222.
  • 5Christensen J, Andreasen F, Poulsen JH, et al. Randomized,concentration-controlled trial of topiramate in refractory focal epilepsy. Neurology, 2003, 61(9) : 1210-1218.
  • 6Bootsma HP, Coolen F, Aldenkamp AP, et al. Topiramate inclinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy Behav,2004, 5(3): 380-387.
  • 7Groselj J, Guerrini R, Van Oene J, et al. Experience with topiramate monotherapy in elderly patients with recent-onset epilepsy. Acta Neurol Seand, 2005, 112(3) : 144-150.
  • 8Donofrio PD, Raskin P, Rosenthal NR, et al. Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study, Clin Ther, 2005, 27(9) : 1420-1431.
  • 9Raskin P, Donofrio PD, Rossenthal NR, et al, Topiramate vs placebo in painful diabetic neuropathy: An',dgesic and metabolic effects. Neurology. 2004, 63(5) : 865-873.
  • 10Ben- Menachem E, Axelsen M, Johanson EH, et al. Predictors of weight loss in adults with toplramte-treated epilepsy. Obes Res, 2003, 11 : 556-562.

共引文献4

同被引文献43

引证文献7

二级引证文献56

国际神经病学神经外科学杂志
2008年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部